Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 288

1.

Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.

Kodama A, Komori K, Hattori K, Yamanouchi D, Kajikuri J, Itoh T.

J Vasc Surg. 2009 May;49(5):1272-81. doi: 10.1016/j.jvs.2008.11.071. Epub 2009 Feb 23.

2.
3.

Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.

Hattori K, Yamanouchi D, Banno H, Kobayashi M, Yamamoto K, Kajikuri J, Itoh T, Komori K.

J Vasc Surg. 2007 Jul;46(1):116-23.

4.

Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.

Yamanouchi D, Banno H, Nakayama M, Sugimoto M, Fujita H, Kobayashi M, Kuwano H, Komori K.

J Vasc Surg. 2005 Oct;42(4):757-64.

5.

Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft.

Maekawa T, Komori K, Morisaki K, Itoh T.

J Vasc Surg. 2012 Dec;56(6):1689-97. doi: 10.1016/j.jvs.2012.05.071. Epub 2012 Aug 1.

6.

Characteristics of the actions by which 5-HT affects electrical and mechanical activities in rabbit jugular vein.

Itoh T, Kajikuri J.

Br J Pharmacol. 2011 Oct;164(3):979-91. doi: 10.1111/j.1476-5381.2011.01373.x.

7.

Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.

Davies MG, Huynh TT, Hagen PO.

J Surg Res. 2000 Jul;92(1):103-7.

PMID:
10864489
8.
9.

L-arginine inhibits smooth muscle cell proliferation of vein graft intimal thickness in hypercholesterolemic rabbits.

Okazaki J, Komori K, Kawasaki K, Eguchi D, Ishida M, Sugimachi K.

Cardiovasc Res. 1997 Dec;36(3):429-36.

PMID:
9534863
10.
11.

Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase.

West N, Guzik T, Black E, Channon K.

Arterioscler Thromb Vasc Biol. 2001 Feb;21(2):189-94.

12.

Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.

Morisaki K, Shibata R, Takahashi N, Ouchi N, Maehara Y, Murohara T, Komori K.

J Vasc Surg. 2011 Dec;54(6):1753-9. doi: 10.1016/j.jvs.2011.06.081. Epub 2011 Sep 3.

13.
14.

Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.

Zhou N, Yu QJ, Si R, Gao HK, Wang T, Gao F, Wang HC, Bian JF.

J Cardiovasc Pharmacol. 2010 Oct;56(4):402-12. doi: 10.1097/FJC.0b013e3181f09ba8.

PMID:
20625311
15.

[Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats].

Deng YZ, Liu SJ, Ma L, Sun ZQ, Chen JJ, Su G, Liu C, Wang GH, Ke J.

Zhonghua Yi Xue Za Zhi. 2007 Jun 26;87(24):1713-6. Chinese.

PMID:
17825157
17.

Characteristics of the actions by which 5-hydroxytryptamine affects electrical and mechanical activities in rabbit jugular vein graft.

Maekawa T, Komori K, Kajikuri J, Itoh T.

Br J Pharmacol. 2012 Jun;166(4):1419-32. doi: 10.1111/j.1476-5381.2012.01867.x.

18.

Pitavastatin inhibits intimal hyperplasia in rabbit vein graft.

Fujita H, Banno H, Yamanouchi D, Kobayashi M, Yamamoto K, Komori K.

J Surg Res. 2008 Aug;148(2):238-43. doi: 10.1016/j.jss.2007.08.017. Epub 2007 Oct 2.

PMID:
18395752
19.

Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.

Zou J, Zhang X, Yang H, Zhu Y, Ma H, Wang S.

Ann Vasc Surg. 2011 May;25(4):538-46. doi: 10.1016/j.avsg.2011.01.003.

PMID:
21549923
20.

Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.

Davis MG, Dalen H, Austerheim AM, Gulbrandsen TF, Svendsen E, Hagen PO.

J Vasc Surg. 1996 Mar;23(3):410-20.

PMID:
8601882

Supplemental Content

Support Center